arrow
S

Saidi Mohiddin

Barts Heart Centre
H指数:42
被引数:7,906

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence and determinants of asymmetric septal hypertrophy (ASH) in diseases of left ventricular hypertrophy (LVH)

左心室肥厚(LVH)疾病中非对称室间隔肥厚(ASH)的患病率及其影响因素

2026-08-030
OAAI
Trientine for hypertrophic cardiomyopathy: a phase 2 trial

三乙基氢氯化铵用于肥厚型心肌病的二期临床试验

2026-07-150
OAAI
Role of multi-modality cardiac imaging in the management of patients with hypertrophic cardiomyopathy in 2025. A Clinical Consensus Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC

Cardim, N.; Haugaa, K.; Mohiddin, S.A.; Hinojar, R.; Hirsch, A.; Szabo, L.; Podlesnikar, T.; Dall’Armellina, E.; Cameli, M.; Mandoli, G.E.; 等. 多模态心脏成像在2025年肥厚型心肌病患者管理中的作用。欧洲心血管影像协会(EACVI)的ESC临床共识声明。Eur. Heart J. Cardiovasc. Imaging 2025, 2025, jeaf282. [Google Scholar] [CrossRef]

2025-11-040
OA
Electromechanically Optimized Right Ventricular Pacing for Obstructive Hypertrophic Cardiomyopathy (EMORI-HCM)

电机械优化右心室起搏治疗梗阻性肥厚型心肌病(EMORI-HCM)

JACC
IF0
2025-08-310
PRE
The Cardiovascular Magnetic Resonance Phenotype of Lamin Heart Disease

拉姆心肌病的心血管磁共振表型

2025-05-140
OA
Dilated cardiomyopathy evaluation with Imagenomics: combining multimodal cardiovascular imaging and genetics

应用影像组学评估扩张型心肌病:结合多模态心血管成像与遗传学

2025-04-241
OAAI
An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy

来自100,000基因组队列的心肌病患者的线粒体变异分析: m.4300A>G是遗传上难以捉摸的肥厚性心肌病的原因

2024-12-050
OAAI
Impact of Catheter Ablation on Atrial Fibrillation Burden and Symptoms in Patients With Hypertrophic Cardiomyopathy

导管消融对肥厚型心肌病患者心房颤动负荷及症状的影响

2024-12-010
PRE
The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging

使用ECG成像的肥厚型心肌病的心律失常底物

2024-08-141
OAAI
Distal Ventricular Pacing for Drug-Refractory Mid-Cavity Obstructive Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial of Personalized Pacing
2024-07-010
OA